pocketful logo
Gland Pharma Ltd logo

Gland Pharma Ltd

NSE: GLAND BSE: 543245

1627.10

(1.90%)

Mon, 30 Mar 2026, 04:50 pm

Gland Pharma Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    28482.27

  • Net Profit

    698.53

  • P/B

    2.87

  • Sector P/E

    31.93

  • P/E

    37.55

  • EV/EBITDA

    16.18

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.96

  • ROCE (Industry)

    16.65

  • RONW (Industry)

    14.66

  • ROE

    7.82

  • ROCE

    11.67

  • Debt/Equity

    0.04

  • EPS (TTM)

    52.45

  • Dividend Yield

    1.04

  • Book Value

    580.41

  • Interest Cover

    26.30

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters51.8351.8351.8351.8351.83
FII7.587.917.396.905.04
DII32.9832.6432.8533.2734.80
Public7.617.637.937.998.33
Government0.000.000.000.000.00

Read More

Technical Analysis

RSI

49.05

MACD

-24.17

50 DMA

1752.99

200 DMA

1833.81

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic232420881955.1018521719.1016161380
Fibonacci20881997.851942.1518521761.851706.151616
Camarilla1887.101865.471843.8318521800.571778.931757.30

Pivots Level: Classic

R3

+472

2324

R2

+236

2088

R1

+103.10

1955.10

1852
1852
Pivot Point
LTP: 1696.10

S1

-132.90

1719.10

S2

-236

1616

S3

-472

1380

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    1676.43

  • 20-EMA

    1690.82

  • 30-EMA

    1707.54

  • 50-EMA

    1728.22

  • 100-EMA

    1757.07

  • 200-EMA

    1770.32

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results
14 Jul 2025dividendFinal Dividend - Rs. - 1814 Aug 2025
20 May 2025dividend₹18.00 Dividend /Share14 Aug 2025
20 May 2025agm
16 Jul 2024dividendFinal Dividend - Rs. - 2016 Aug 2024
22 May 2024dividend₹20.00 Dividend /Share16 Aug 2024
22 May 2024agm
18 May 2023agm
19 May 2022agm

Read More

Peer Comparison

Gland Pharma Ltd logo

Gland Pharma Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Gland Pharma Ltd About

Gland Pharma is primarily engaged in manufacturing injectable formulations. The Company’s shares are listed on BSE Limited and National Stock Exchange of India Limited.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1978

Headquarters

CEO

SRINIVAS SADU

Employees

Contact

Website icon

Website

http://www.glandpharma.com

Email icon

Email

investors@glandpharma.com

Phone icon

Phone

91-40-30510999

Location icon

Location

Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal, Hyderabad, Telangana, 500043

Read More

Gland Pharma Ltd Company History

YearHistory
2019
  • The company filed Dexrazoxane for Injection, its first filing with the National Medical Products Administration, China, and received clinical waiver
2020
  • Gland Pharma along with its partners MAIA Pharmaceuticals, Inc. and Athenex Pharmaceutical Division announce the launch of a Ready-to-Use Bivalirudin Injection in the United States of America
2021
  • Gland Pharma received approval for generic Foscarnet Sodium Injection, Single-Dose Bag for Infusion
  • Gland Pharma receives Tentative Approval for Sugammadex Injection
  • Gland Pharma receives tentative approval for Cangrelor injection
2022
  • Gland Pharma enters into put option agreement to acquire 100% of Cenexi Group
  • Gland Pharma announces launch of Bortezomib for Injection in US market
2024
  • The Company received approval from the United States Food and Drug Administration (US FDA) for Plerixafor Injection

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VIEIFBuy8385561588.6921 Mar 2025
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUNDBuy10162191588.6921 Mar 2025
FOSUN PHARMA INDUSTRIAL PTE. LTD.Sell99000001771.8119 Jun 2024
UBS PRINCIPAL CAPITAL ASIA LIMITEDBuy8250001771.0519 Jun 2024
NICOMAC MACHINERY PRIVATE LIMITEDSell19554521735.3109 Apr 2024
LAKUMI TRUSTSell61654861739.109 Apr 2024
GRAVITON RESEARCH CAPITAL LLPBuy11103001698.7209 Aug 2023
GRAVITON RESEARCH CAPITAL LLPSell11103001700.0209 Aug 2023
MORGAN STANLEY INVESTMENT FUNDS EMERGING MARKETS EQUITY FUNDSell960271930.6922 May 2023
NICOMAC MACHINERY PRIVATE LIMITEDSell53793433200.6621 Apr 2022

Read More

Gland Pharma Ltd News

Gland Pharma schedules analyst meeting for March 23

Gland Pharma Limited announces analyst and institutional investor meeting with Ventura Securities scheduled for March 23, 2026, as per regulatory compliance under SEBI regulations.

18 Mar 2026

companies

Gland Pharma schedules analyst meetings for March

Gland Pharma Limited announces analyst and institutional investor meetings scheduled for March 18-20, 2026, including a Non-Deal Roadshow with Elara (USA) featuring one-on-one meetings.

13 Mar 2026

companies

Gland Pharma Faces GST Demand of INR 5.03 Cr

Gland Pharma receives GST tax demand order of INR 5.03 crores with penalty of INR 1.26 crores for FY 2019-20. Company plans to file appeal against the order.

06 Mar 2026

stocks

Gland Pharma Gets USFDA Nod for Eye Solution

Gland Pharma receives tentative USFDA approval for Brimonidine Tartrate Eye Solution, matching Lumify Eye Solution with US sales projected at $39 million by September 2025.

04 Mar 2026

stocks

Gland Pharma CEO Shyamakant Giri Resigns

Gland Pharma announces resignation of CEO Shyamakant Giri effective April 30, 2026. Board accepts resignation following recommendation from Nomination and Remuneration Committee.

03 Mar 2026

stocks

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800